Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Marinus Pharmaceuticals Inc’s current trading price is -17.58% away from its 52-week high, while its distance from the 52-week low is 66.59%. The stock’s price range during this period has varied between $5.57 and $11.26. The company, active in the Healthcare sector, saw a trading volume of around 0.56 million for the day, considerably higher average daily volume of 0.44 million observed over the last three months.
Marinus Pharmaceuticals Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $11.26 on 01/08/24, and the lowest price during the same period was recorded at $5.57 on 11/10/23.
How Financial Performance Impacts Market Capitalization
Marinus Pharmaceuticals Inc (MRNS) has experienced a quarterly rise of 9.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 507.06M and boasts a workforce of 165 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.68, with a change in price of +2.08. Similarly, Marinus Pharmaceuticals Inc recorded 421,937 in trading volume during the last 100 days, posting a change of +28.89%.
How MRNS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MRNS stands at 6.58. Similarly, the long-term debt-to-equity ratio is also 5.71.
MRNS Stock Stochastic Average
As of today, the raw stochastic average of Marinus Pharmaceuticals Inc over the last 50 days is at 36.33%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 48.09%. Further, the company’s Stochastic %K and %D values for the last 20 days were 30.64% and 27.89%, respectively.
MRNS Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant loss of -14.63% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 36.07%. Over the past 30 days, the price of MRNS has leaped by -8.12%. And in the last five days, it has surged by 0.43%.
